Evidence map›Paper›PMID 41250202›Full record

ArticleBreast cancer research : BCR2025

Automated quantification of Ki-67 expression in breast cancer from H&E-stained slides using a transformer-based regression model.

Abadh K Chaurasia, Patrick W Toohey, Matthew T Bennett, Helen C Harris, Alex W Hewitt

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abadh K ChaurasiaPandani Solutions Pty Ltd, Hobart, Australia. abadh.chaurasia@utas.edu.au.
Patrick W TooheyPandani Solutions Pty Ltd, Hobart, Australia.
Matthew T BennettPandani Solutions Pty Ltd, Hobart, Australia.
Helen C HarrisDepartment of Pathology, Royal Hobart Hospital, Hobart, Australia.
Alex W HewittMenzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccurate quantification of the Ki-67 proliferation index is essential for breast cancer prognosis and treatment planning. Current automated methods, including classical and deep learning approaches based on cell detection or segmentation, often face challenges due to densely packed nuclei, morphological variability, and inter-laboratory differences. Since Hematoxylin and Eosin (H&E) staining is routinely performed, accurately estimating Ki-67 from these slides could save resources by eliminating the need for additional immunohistochemical (IHC) staining. We developed and validated a transformer-based regression model to estimate Ki-67 expression directly from H&E-stained Whole Slide Images (WSIs).

methodsWe used seven public datasets to select optimal transformer-based architectures and hyperparameters. WSIs underwent preprocessing to filter poor-quality patches, with a classification model identifying gradable patches. Only gradable patches proceeded to Ki-67 quantification. Initially, a regression model was trained on IHC-stained patches using independently annotated datasets, bypassing segmentation methods. This model generated pseudo-labels for unlabeled IHC patches, which were then paired with corresponding H&E images, with a separate model trained using only these H&E patches. Both models were evaluated separately across 1153 H&E and 843 IHC-stained WSIs, employing metrics such as R

resultsOur regression model had good predictive accuracy, with R

conclusionOur approach precisely quantifies Ki-67 expression and automates hotspot detection from WSIs, providing a scalable tool for digital pathology workflows. The cross-modality model potentially quantifies molecular expression from morphological features using H&E-stained WSIs.

Indexed as

Biomarkers, TumorBreast NeoplasmsImage Processing, Computer-AssistedKi-67 AntigenCell ProliferationEosine Yellowish-(YS)FemaleHematoxylinHumansImmunohistochemistryPrognosisRegression AnalysisStaining and LabelingBiomarkers, TumorEosine Yellowish-(YS)HematoxylinKi-67 AntigenBreast CancerDigital PathologyHematoxylin and EosinImmunohistochemistryKi-67 IndexRegression AnalysisVision Transformer

Identifiers

PMID41250202
PMCPMC12625586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.